Rheumatology Advance Access originally published online on March 31, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology 2003; 42: 607-613
© 2003 British Society for Rheumatology
Editorial |
Tackling ischaemic heart disease in rheumatoid arthritis
1 Department of Rheumatology, Dudley Group of Hospitals NHS Trust and
2 Department of Rheumatology, Division of Immunity and Infection, The Medical School, University of Birmingham, UK
| The first 150 words of the full text of this article appear below. |
Rheumatoid arthritis (RA) is the commonest form of chronic inflammatory arthritis. It causes significant disability and the efforts of the scientific community have concentrated on controlling symptoms, decelerating joint damage and improving function. However, it has been known for 50 yr [1] that RA is also associated with increased mortality [2, 3]. For severe RA, this compares to that of major killers such as triple-vessel coronary heart disease (CHD) and some lymphomas [4, 5]. Despite advances in treatment, the mortality of RA does not appear to have changed over the last three decades [6, 7]. Its control, therefore, merits at least as much attention as the reduction of disability. An obvious target is reduction of cardiovascular mortality, which accounts for almost half of all deaths in RA [2, 3, 8]. In this article we describe
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. J.L. PETERS, M. M.J. NIELEN, H. G. RATERMAN, R. A. VERHEIJ, F. G. SCHELLEVIS, and M. T. NURMOHAMED Increased Cardiovascular Disease in Patients with Inflammatory Arthritis in Primary Care: A Cross-sectional Observation J Rheumatol, September 1, 2009; 36(9): 1866 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V F Panoulas, S N Nikas, J P Smith, K M J Douglas, P Nightingale, H J Milionis, G J Treharne, T E Toms, M D Kita, and G D Kitas Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis Ann Rheum Dis, November 1, 2008; 67(11): 1550 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. F. Panoulas, G. S. Metsios, A. V. Pace, H. John, G. J. Treharne, M. J. Banks, and G. D. Kitas Hypertension in rheumatoid arthritis Rheumatology, September 1, 2008; 47(9): 1286 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Metsios, A. Stavropoulos-Kalinoglou, V. F. Panoulas, Y. Koutedakis, A. M. Nevill, K. M. J. Douglas, M. Kita, and G. D. Kitas New resting energy expenditure prediction equations for patients with rheumatoid arthritis Rheumatology, April 1, 2008; 47(4): 500 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Metsios, A. Stavropoulos-Kalinoglou, J. J. C. S. Veldhuijzen van Zanten, G. J. Treharne, V. F. Panoulas, K. M. J. Douglas, Y. Koutedakis, and G. D. Kitas Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review Rheumatology, March 1, 2008; 47(3): 239 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis Rheumatology, January 1, 2008; 47(1): 72 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Metsios, A. Stavropoulos-Kalinoglou, K. M. J. Douglas, Y. Koutedakis, A. M. Nevill, V. F. Panoulas, M. Kita, and G. D. Kitas Blockade of tumour necrosis factor-{alpha} in rheumatoid arthritis: effects on components of rheumatoid cachexia Rheumatology, December 1, 2007; 46(12): 1824 - 1827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Stavropoulos-Kalinoglou, G. S Metsios, Y. Koutedakis, A. M Nevill, K. M Douglas, A. Jamurtas, J. J C S V. van Zanten, M. Labib, and G. D Kitas Redefining overweight and obesity in rheumatoid arthritis patients Ann Rheum Dis, October 1, 2007; 66(10): 1316 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. John, E. D. Hale, G. J. Treharne, and G. D. Kitas Patient education on cardiovascular aspects of rheumatoid disease: an unmet need Rheumatology, October 1, 2007; 46(10): 1513 - 1516. [Full Text] [PDF]
|
|
|
|
|
|
V. F. Panoulas, K. M. J. Douglas, H. J. Milionis, A. Stavropoulos-Kalinglou, P. Nightingale, M. D. Kita, A. L. Tselios, G. S. Metsios, M. S. Elisaf, and G. D. Kitas Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis Rheumatology, September 1, 2007; 46(9): 1477 - 1482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Montagna, F. Cacciapuoti, R. Buono, D. Manzella, G. A. Mennillo, A. Arciello, G. Valentini, and G. Paolisso Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis Diabetes and Vascular Disease Research, June 1, 2007; 4(2): 130 - 135. [Abstract] [PDF]
|
|
|
|
|
|
A. Young, G. Koduri, M. Batley, E. Kulinskaya, A. Gough, S. Norton, J. Dixey, and on behalf of the Early Rheumatoid Arthritis Study Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis Rheumatology, February 1, 2007; 46(2): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K M J Douglas, E Ladoyanni, G J Treharne, E D Hale, N Erb, and G D Kitas Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions Ann Rheum Dis, October 1, 2006; 65(10): 1341 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Witney, G. J. Treharne, M. Tavakoli, A. C. Lyons, K. Vincent, D. L. Scott, and G. D. Kitas The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis Rheumatology, August 1, 2006; 45(8): 975 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K M J Douglas, A V Pace, G J Treharne, A Saratzis, P Nightingale, N Erb, M J Banks, and G D Kitas Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome Ann Rheum Dis, March 1, 2006; 65(3): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Treharne, A. C. Lyons, E. D. Hale, K. M. J. Douglas, and G. D. Kitas 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Rheumatology, January 1, 2006; 45(1): 1 - 5. [Full Text] [PDF]
|
|
|
|
|
|
G. J. Treharne, E. D. Hale, A. C. Lyons, D. A. Booth, M. J. Banks, N. Erb, K. M. Douglas, D. L. Mitton, and G. D. Kitas Cardiovascular disease and psychological morbidity among rheumatoid arthritis patients Rheumatology, February 1, 2005; 44(2): 241 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mpofu, V. V. Kaushik, G. Grundy, and R. J. Moots Microalbuminuria: is it a predictor of ischaemic heart disease in rheumatoid arthritis? Rheumatology, April 1, 2004; 43(4): 537 - 538. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Whittle and R. A. Hughes Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review Rheumatology, March 1, 2004; 43(3): 267 - 271. [Abstract] [Full Text] [PDF]
|
|